This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sawtell, N. M.
Right arrow Articles by Thompson, R. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sawtell, N. M.
Right arrow Articles by Thompson, R. L.

 Previous Article  |  Next Article 

J Virol, July 1998, p. 5343-5350, Vol. 72, No. 7
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.

The Latent Herpes Simplex Virus Type 1 Genome Copy Number in Individual Neurons Is Virus Strain Specific and Correlates with Reactivation

N. M. Sawtell,1 D. K. Poon,2 C. S. Tansky,1 and R. L. Thompson2,*

Division of Infectious Diseases, Children's Hospital Medical Center, Cincinnati, Ohio 45229-3039,1 and Department of Molecular Genetics, Microbiology, and Biochemistry, University of Cincinnati Medical Center, Cincinnati, Ohio 45267-05242

Received 10 December 1997/Accepted 12 March 1998

The viral genetic elements that determine the in vivo reactivation efficiencies of fully replication competent wild-type herpes simplex virus (HSV) strains have not been identified. Among the common laboratory strains, KOS reactivates in vivo at a lower efficiency than either strain 17syn+ or strain McKrae. An important first step in understanding the molecular basis for this observation is to distinguish between viral genetic factors that regulate the establishment of latency from those that directly regulate reactivation. Reported here are experiments performed to determine whether the reduced reactivation of KOS was associated with a reduced ability to establish or maintain latent infections. For comparative purposes, latent infections were quantified by (i) quantitative PCR on DNA extracted from whole ganglia, (ii) the number of latency-associated transcript (LAT) promoter-positive neurons, using KOS and 17syn+ LAT promoter-beta -galactosidase reporter mutants, and (iii) contextual analysis of DNA. Mice latently infected with 17syn+-based strains contained more HSV type 1 (HSV-1) DNA in their ganglia than those infected with KOS strains, but this difference was not statistically significant. The number of latently infected neurons also did not differ significantly between ganglia latently infected with either the low- or high-reactivator strains. In addition to the number of latent sites, the number of viral genome copies within the individual latently infected neurons has recently been demonstrated to be variable. Interestingly, neurons latently infected with KOS contained significantly fewer viral genome copies than those infected with either 17syn+ or McKrae. Thus, the HSV-1 genome copy number profile is viral strain specific and positively correlates with the ability to reactivate in vivo. This is the first demonstration that the number of HSV genome copies within individual latently infected neurons is regulated by viral genetic factors. These findings suggest that the latent genome copy number may be an important parameter for subsequent induced reactivation in vivo.


* Corresponding author. Mailing address: University of Cincinnati Medical Center, Department of Molecular Genetics, Microbiology, and Biochemistry, 231 Bethesda Ave., Cincinnati, OH 45267-0524. Phone: (513) 558-0063. Fax: (513) 558-8474. E-mail: Richard.Thompson{at}UC.edu.


J Virol, July 1998, p. 5343-5350, Vol. 72, No. 7
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Hufner, K., Horn, A., Derfuss, T., Glon, C., Sinicina, I., Arbusow, V., Strupp, M., Brandt, T., Theil, D. (2009). Fewer Latent Herpes Simplex Virus Type 1 and Cytotoxic T Cells Occur in the Ophthalmic Division than in the Maxillary and Mandibular Divisions of the Human Trigeminal Ganglion and Nerve. J. Virol. 83: 3696-3703 [Abstract] [Full Text]  
  • Proenca, J. T., Coleman, H. M., Connor, V., Winton, D. J., Efstathiou, S. (2008). A historical analysis of herpes simplex virus promoter activation in vivo reveals distinct populations of latently infected neurones. J. Gen. Virol. 89: 2965-2974 [Abstract] [Full Text]  
  • Margolis, T. P., Elfman, F. L., Leib, D., Pakpour, N., Apakupakul, K., Imai, Y., Voytek, C. (2007). Spontaneous Reactivation of Herpes Simplex Virus Type 1 in Latently Infected Murine Sensory Ganglia. J. Virol. 81: 11069-11074 [Abstract] [Full Text]  
  • Hoshino, Y., Pesnicak, L., Cohen, J. I., Straus, S. E. (2007). Rates of Reactivation of Latent Herpes Simplex Virus from Mouse Trigeminal Ganglia Ex Vivo Correlate Directly with Viral Load and Inversely with Number of Infiltrating CD8+ T Cells. J. Virol. 81: 8157-8164 [Abstract] [Full Text]  
  • Thompson, R. L., Sawtell, N. M. (2006). Evidence that the Herpes Simplex Virus Type 1 ICP0 Protein Does Not Initiate Reactivation from Latency In Vivo. J. Virol. 80: 10919-10930 [Abstract] [Full Text]  
  • Orlando, J. S., Balliet, J. W., Kushnir, A. S., Astor, T. L., Kosz-Vnenchak, M., Rice, S. A., Knipe, D. M., Schaffer, P. A. (2006). ICP22 Is Required for Wild-Type Composition and Infectivity of Herpes Simplex Virus Type 1 Virions. J. Virol. 80: 9381-9390 [Abstract] [Full Text]  
  • Burgos, J. S., Ramirez, C., Sastre, I., Valdivieso, F. (2006). Effect of apolipoprotein e on the cerebral load of latent herpes simplex virus type 1 DNA.. J. Virol. 80: 5383-5387 [Abstract] [Full Text]  
  • Miller, C. S., Danaher, R. J., Jacob, R. J. (2006). ICP0 Is Not Required for Efficient Stress-Induced Reactivation of Herpes Simplex Virus Type 1 from Cultured Quiescently Infected Neuronal Cells.. J. Virol. 80: 3360-3368 [Abstract] [Full Text]  
  • Wang, K., Lau, T. Y., Morales, M., Mont, E. K., Straus, S. E. (2005). Laser-Capture Microdissection: Refining Estimates of the Quantity and Distribution of Latent Herpes Simplex Virus 1 and Varicella-Zoster Virus DNA in Human Trigeminal Ganglia at the Single-Cell Level. J. Virol. 79: 14079-14087 [Abstract] [Full Text]  
  • Sawtell, N. M., Thompson, R. L. (2004). Comparison of Herpes Simplex Virus Reactivation in Ganglia In Vivo and in Explants Demonstrates Quantitative and Qualitative Differences. J. Virol. 78: 7784-7794 [Abstract] [Full Text]  
  • O'Neil, J. E., Loutsch, J. M., Aguilar, J. S., Hill, J. M., Wagner, E. K., Bloom, D. C. (2004). Wide Variations in Herpes Simplex Virus Type 1 Inoculum Dose and Latency-Associated Transcript Expression Phenotype Do Not Alter the Establishment of Latency in the Rabbit Eye Model. J. Virol. 78: 5038-5044 [Abstract] [Full Text]  
  • Chen, S.-H., Pearson, A., Coen, D. M., Chen, S.-H. (2004). Failure of Thymidine Kinase-Negative Herpes Simplex Virus To Reactivate from Latency following Efficient Establishment. J. Virol. 78: 520-523 [Abstract] [Full Text]  
  • Mador, N., Braun, E., Haim, H., Ariel, I., Panet, A., Steiner, I. (2003). Transgenic Mouse with the Herpes Simplex Virus Type 1 Latency-Associated Gene: Expression and Function of the Transgene. J. Virol. 77: 12421-12429 [Abstract] [Full Text]  
  • Thompson, R. L., Shieh, M. T., Sawtell, N. M. (2003). Analysis of Herpes Simplex Virus ICP0 Promoter Function in Sensory Neurons during Acute Infection, Establishment of Latency, and Reactivation In Vivo. J. Virol. 77: 12319-12330 [Abstract] [Full Text]  
  • Lundberg, P., Welander, P., Openshaw, H., Nalbandian, C., Edwards, C., Moldawer, L., Cantin, E. (2003). A Locus on Mouse Chromosome 6 That Determines Resistance to Herpes Simplex Virus Also Influences Reactivation, While an Unlinked Locus Augments Resistance of Female Mice. J. Virol. 77: 11661-11673 [Abstract] [Full Text]  
  • Levin, M. J., Cai, G.-Y., Manchak, M. D., Pizer, L. I. (2003). Varicella-Zoster Virus DNA in Cells Isolated from Human Trigeminal Ganglia. J. Virol. 77: 6979-6987 [Abstract] [Full Text]  
  • Sawtell, N. M. (2003). Quantitative Analysis of Herpes Simplex Virus Reactivation In Vivo Demonstrates that Reactivation in the Nervous System Is Not Inhibited at Early Times Postinoculation. J. Virol. 77: 4127-4138 [Abstract] [Full Text]  
  • Thompson, R. L., Sawtell, N. M. (2001). Herpes Simplex Virus Type 1 Latency-Associated Transcript Gene Promotes Neuronal Survival. J. Virol. 75: 6660-6675 [Abstract] [Full Text]  
  • Arthur, J. L., Scarpini, C. G., Connor, V., Lachmann, R. H., Tolkovsky, A. M., Efstathiou, S. (2001). Herpes Simplex Virus Type 1 Promoter Activity during Latency Establishment, Maintenance, and Reactivation in Primary Dorsal Root Neurons In Vitro. J. Virol. 75: 3885-3895 [Abstract] [Full Text]  
  • Piret, J., Lamontagne, J., Désormeaux, A., Bergeron, M. G. (2001). Efficacies of Gel Formulations Containing Foscarnet, Alone or Combined with Sodium Lauryl Sulfate, against Establishment and Reactivation of Latent Herpes Simplex Virus Type 1. Antimicrob. Agents Chemother. 45: 1030-1036 [Abstract] [Full Text]  
  • Han, X., Lundberg, P., Tanamachi, B., Openshaw, H., Longmate, J., Cantin, E. (2001). Gender Influences Herpes Simplex Virus Type 1 Infection in Normal and Gamma Interferon-Mutant Mice. J. Virol. 75: 3048-3052 [Abstract] [Full Text]  
  • Cohrs, R. J., Randall, J., Smith, J., Gilden, D. H., Dabrowski, C., van der Keyl, H., Tal-Singer, R. (2000). Analysis of Individual Human Trigeminal Ganglia for Latent Herpes Simplex Virus Type 1 and Varicella-Zoster Virus Nucleic Acids Using Real-Time PCR. J. Virol. 74: 11464-11471 [Abstract] [Full Text]  
  • Stingley, S. W., Ramirez, J. J. G., Aguilar, S. A., Simmen, K., Sandri-Goldin, R. M., Ghazal, P., Wagner, E. K. (2000). Global Analysis of Herpes Simplex Virus Type 1 Transcription Using an Oligonucleotide-Based DNA Microarray. J. Virol. 74: 9916-9927 [Abstract] [Full Text]  
  • Thackray, A. M., Field, H. J. (2000). The effects of antiviral therapy on the distribution of herpes simplex virus type 1 to ganglionic neurons and its consequences during, immediately following and several months after treatment. J. Gen. Virol. 81: 2385-2396 [Abstract] [Full Text]  
  • Clementi, M. (2000). Quantitative Molecular Analysis of Virus Expression and Replication. J. Clin. Microbiol. 38: 2030-2036 [Full Text]  
  • Liu, T., Khanna, K. M., Chen, X., Fink, D. J., Hendricks, R. L. (2000). Cd8+ T Cells Can Block Herpes Simplex Virus Type 1 (HSV-1) Reactivation from Latency in Sensory Neurons. JEM 191: 1459-1466 [Abstract] [Full Text]  
  • Perng, G., Jones, C., Ciacci-Zanella, J., Stone, M., Henderson, G., Yukht, A., Slanina, S. M., Hofman, F. M., Ghiasi, H., Nesburn, A. B., Wechsler, S. L. (2000). Virus-Induced Neuronal Apoptosis Blocked by the Herpes Simplex Virus Latency-Associated Transcript. Science 287: 1500-1503 [Abstract] [Full Text]  
  • Perng, G.-C., Slanina, S. M., Yukht, A., Ghiasi, H., Nesburn, A. B., Wechsler, S. L. (2000). The Latency-Associated Transcript Gene Enhances Establishment of Herpes Simplex Virus Type 1 Latency in Rabbits. J. Virol. 74: 1885-1891 [Abstract] [Full Text]  
  • Preston, C. M. (2000). Repression of viral transcription during herpes simplex virus latency. J. Gen. Virol. 81: 1-19 [Full Text]  
  • Thompson, R. L., Sawtell, N. M. (2000). Replication of Herpes Simplex Virus Type 1 within Trigeminal Ganglia Is Required for High Frequency but Not High Viral Genome Copy Number Latency. J. Virol. 74: 965-974 [Abstract] [Full Text]  
  • Pevenstein, S. R., Williams, R. K., McChesney, D., Mont, E. K., Smialek, J. E., Straus, S. E. (1999). Quantitation of Latent Varicella-Zoster Virus and Herpes Simplex Virus Genomes in Human Trigeminal Ganglia. J. Virol. 73: 10514-10518 [Abstract] [Full Text]  
  • LeBlanc, R. A., Pesnicak, L., Cabral, E. S., Godleski, M., Straus, S. E. (1999). Lack of Interleukin-6 (IL-6) Enhances Susceptibility to Infection but Does Not Alter Latency or Reactivation of Herpes Simplex Virus Type 1 in IL-6 Knockout Mice. J. Virol. 73: 8145-8151 [Abstract] [Full Text]  
  • Zheng, X., Marquart, M. E., Loustch, J. M., Shah, P., Sainz, B., Ray, A., O’Callaghan, R. J., Kaufman, H. E., Hill, J. M. (1999). HSV-1 Migration in Latently Infected and Naive Rabbits after Penetrating Keratoplasty. IOVS 40: 2490-2497 [Abstract] [Full Text]  
  • Lachmann, R., Sadarangani, M, Atkinson, H., Efstathiou, S (1999). An analysis of herpes simplex virus gene expression during latency establishment and reactivation. J. Gen. Virol. 80: 1271-1282 [Abstract]  
  • Cantin, E., Tanamachi, B., Openshaw, H. (1999). Role for Gamma Interferon in Control of Herpes Simplex Virus Type 1 Reactivation. J. Virol. 73: 3418-3423 [Abstract] [Full Text]  
  • Noisakran, S., Campbell, I. L., Carr, D. J. J. (1999). Ectopic Expression of DNA Encoding IFN-{alpha}1 in the Cornea Protects Mice from Herpes Simplex Virus Type 1-Induced Encephalitis. J. Immunol. 162: 4184-4190 [Abstract] [Full Text]  
  • Sawtell, N. M. (1998). The Probability of In Vivo Reactivation of Herpes Simplex Virus Type 1 Increases with the Number of Latently Infected Neurons in the Ganglia. J. Virol. 72: 6888-6892 [Abstract] [Full Text]